Pharmacokinetic concerns related to the AIDS Clinical Trial Group (ACTG) A5262 trial

AIDS. 2012 Jan 28;26(3):398-400; author reply 397-8. doi: 10.1097/QAD.0b013e32834e9d9e.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Female
  • HIV Infections / drug therapy*
  • HIV-1 / drug effects*
  • Humans
  • Male
  • Pyrrolidinones / therapeutic use*
  • Ritonavir / therapeutic use*
  • Sulfonamides / therapeutic use*

Substances

  • Anti-HIV Agents
  • Pyrrolidinones
  • Sulfonamides
  • Ritonavir